CD63 and precursor B-cell acute lymphoblastic leukemia: Specifically, ExoQuick (Figure S2A) and SEC (Figure S2B) isolate EV subpopulations from pediatric B-ALL CCM that are enriched for CD63 or CD81, respectively.